Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Xeris PharmaceuticalsSyros PharmaceuticalsOptiNoseGeronImmune Design
SymbolNASDAQ:XERSNASDAQ:SYRSNASDAQ:OPTNNASDAQ:GERNNASDAQ:IMDZ
Price Information
Current Price$12.80$7.56$5.83$1.16$5.85
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$27.00$15.8333$27.25$3.3250$7.00
% Upside from Price Target110.94% upside109.44% upside367.41% upside186.64% upside19.66% upside
Trade Information
Market Cap$330.83 million$313.98 million$250.06 million$216.36 million$282.96 million
BetaN/A1.940.932.683.48
Average Volume222,166179,390174,8482,619,792374,216
Sales & Book Value
Annual Revenue$2.46 million$2.05 million$7.07 million$1.07 million$2.20 million
Price / Sales140.18156.4934.03202.20128.62
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.61 per share$2.34 per share$2.88 per share$0.95 per share$1.91 per share
Price / Book3.553.232.021.223.06
Profitability
Net Income$-60,080,000.00$-62,280,000.00$-106,660,000.00$-27,020,000.00$-54,760,000.00
EPS($4.99)($1.91)($2.68)($0.16)($1.75)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-2,997.96%-3,012.04%-983.22%-3,713.04%-2,483.00%
Return on Equity (ROE)-75.93%-74.28%-81.04%-17.53%-49.56%
Return on Assets (ROA)-52.76%-57.49%-46.26%-16.98%-46.21%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.30%0.02%0.79%N/AN/A
Current Ratio11.45%5.19%6.95%24.94%11.33%
Quick Ratio11.45%5.19%6.74%24.94%11.32%
Ownership Information
Institutional Ownership Percentage59.43%56.16%63.68%31.39%61.72%
Insider Ownership Percentage7.43%14.80%44.30%7.50%18.10%
Miscellaneous
Employees90761021748
Shares Outstanding26.94 million42.43 million41.26 million186.52 million48.37 million
Next Earnings Date8/12/2019 (Estimated)8/6/2019 (Estimated)8/13/2019 (Estimated)7/30/2019 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableOptionableOptionable
 Xeris PharmaceuticalsSyros PharmaceuticalsOptiNoseGeronImmune Design

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel